INSTITUTION'S PROFILE
Botswana Harvard AIDS Institute Partnership (BHP), Gaborone, Botswana.
Publications (1)
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Journal: Lancet (London, England)
Publication date: 2022
Journal: Lancet (London, England)
Publication Year: 2022